Label: CONJU PRINCESS BB- arbutin cream

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated January 24, 2011

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Active ingredient: titanium dioxide, arbutin, adenosine
  • INACTIVE INGREDIENT

    Inactive ingredient: water, titanium dioxide,cyclopentasiloxzne, ethylhexyl methoxycinnamate,propylene glycol, cyclohexasiloxane, butylene glycol dicaprylate/dicaprate, cetyl/peg/ppe-10/1 dimethicone, dimethicone,hexyl laurate, arbutin, tale, PEG-10 dimethicone, panax ginseng root extract, sorbitan, olivate, magnesium sulfate, sorbitan sesquioleate, disteardimonium hectorite,quaternium-19bentonite, chamomilla recutita (matricaria) flower extract, silica, triethyl citrate, allantoin, tocopheryl acetate, dipotassium clycyrrhizate, iron oxide (CI 77492), iron oxide (CI 77491), iron oxide (CI 77499), ultramarines (CI 77007), triethoxycaprylylsilane, propylparaben, methylparaben, phenoxyethanol, adenosine, mica, sodim hyaluronate
  • PURPOSE

    helps prevent sunburn
  • KEEP OUT OF REACH OF CHILDREN

    keep out of reach of the children
  • INDICATIONS & USAGE

    After following the daily skin care routine, apply the Conju Princess BB Cream generously onface and sensitive area. Reapply it again every two hours if sensitive exposure is contrast and also be used as a make-up base
  • WARNINGS

    Warning
    For external use only
    When using this product
    ■ Avoid eye area. If contact occurs, rinse eyes thoroughly　with water
    ■ If following abnormal symptoms occurs after use, stop use and ask doctor
       red specks, swelling, itching

  • DOSAGE & ADMINISTRATION

    - for external use only

    - apply frequently when needed
  • PRINCIPAL DISPLAY PANEL

    package label
  • INGREDIENTS AND APPEARANCE
    CONJU PRINCESS BB 
    arbutin cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:59915-1001
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE10.15 mL  in 100 mL
    ARBUTIN (UNII: C5INA23HXF) (ARBUTIN - UNII:C5INA23HXF) ARBUTIN2 mL  in 100 mL
    ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567) ADENOSINE0.04 mL  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)  
    OCTINOXATE (UNII: 4Y5P7MUD51)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    CYCLOMETHICONE 6 (UNII: XHK3U310BA)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    DIMETHICONE (UNII: 92RU3N3Y1O)  
    HEXYL LAURATE (UNII: 4CG9F9W01Q)  
    TALC (UNII: 7SEV7J4R1U)  
    ASIAN GINSENG (UNII: CUQ3A77YXI)  
    SORBITAN OLIVATE (UNII: MDL271E3GR)  
    MAGNESIUM SULFATE, UNSPECIFIED (UNII: DE08037SAB)  
    SORBITAN SESQUIOLEATE (UNII: 0W8RRI5W5A)  
    HECTORITE (UNII: 08X4KI73EZ)  
    BENTONITE (UNII: A3N5ZCN45C)  
    CHAMOMILE (UNII: FGL3685T2X)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  
    ALLANTOIN (UNII: 344S277G0Z)  
    .ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)  
    LICORICE (UNII: 61ZBX54883)  
    FERRIC OXIDE RED (UNII: 1K09F3G675)  
    FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
    FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
    OCTYLTRIETHOXYSILANE (UNII: LDC331P08E)  
    PROPYLPARABEN (UNII: Z8IX2SC1OH)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    MICA (UNII: V8A1AW0880)  
    HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:59915-1001-130 mL in 1 TUBE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other01/24/2011
    Labeler - Conju Inc (012345486)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!